Equifax (NYSE:EFX) Issues FY 2019 Earnings Guidance

Equifax (NYSE:EFX) issued an update on its FY 2019 earnings guidance on Wednesday morning. The company provided EPS guidance of $5.57-5.77 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.64. The company issued revenue guidance of $3.425-3.525 billion, compared to the consensus revenue estimate of $3.47 billion.Equifax also updated its FY19 guidance to $5.57-5.77 EPS.

EFX stock traded up $4.75 on Friday, reaching $142.34. 870,403 shares of the company were exchanged, compared to its average volume of 922,953. Equifax has a 12 month low of $88.68 and a 12 month high of $144.03. The company has a fifty day simple moving average of $135.34. The stock has a market capitalization of $17.19 billion, a price-to-earnings ratio of 24.58, a PEG ratio of 2.95 and a beta of 1.24. The company has a quick ratio of 0.57, a current ratio of 0.57 and a debt-to-equity ratio of 1.02.

Equifax (NYSE:EFX) last announced its earnings results on Wednesday, July 24th. The credit services provider reported $1.40 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.36 by $0.04. Equifax had a negative net margin of 12.52% and a positive return on equity of 21.85%. The business had revenue of $880.00 million for the quarter, compared to analyst estimates of $873.74 million. During the same quarter in the previous year, the firm posted $1.56 earnings per share. Equifax’s revenue was up .4% compared to the same quarter last year. On average, sell-side analysts anticipate that Equifax will post 5.63 earnings per share for the current fiscal year.

A number of research firms have weighed in on EFX. Deutsche Bank reiterated a hold rating on shares of United Parcel Service in a research note on Tuesday, July 2nd. Barclays lifted their price target on shares of WEX from $222.00 to $238.00 and gave the stock an overweight rating in a research note on Monday, May 6th. Robert W. Baird lifted their price target on shares of Verisign from $210.00 to $240.00 and gave the stock an outperform rating in a research note on Friday. Stephens decreased their price target on shares of O’Reilly Automotive from $440.00 to $430.00 and set an overweight rating on the stock in a research note on Friday. Finally, Royal Bank of Canada set a $184.00 price target on shares of Jazz Pharmaceuticals and gave the stock a buy rating in a research note on Wednesday, July 3rd. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have issued a buy rating to the company’s stock. The stock has a consensus rating of Hold and an average price target of $131.75.

About Equifax

Equifax Inc provides information solutions and human resources business process outsourcing services for businesses, governments, and consumers. The company operates through four segments: U.S. Information Solutions (USIS), International, Workforce Solutions, and Global Consumer Solutions. The USIS segment offers consumer and commercial information services, such as credit information and credit scoring, credit modeling and portfolio analytics, locate, fraud detection and prevention, identity verification, and other consulting; mortgage loan origination information; financial marketing; and identity management services.

Featured Article: What is the Federal Reserve?

Earnings History and Estimates for Equifax (NYSE:EFX)

Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.